Guidance for diabetic patients in Ramadhan

This is a brief guidance for diabetic patients to aid them in deciding whether they should fast in the holy month of Ramadhan and if so, what adjustments to make to their medication. There is a comprehensive guidance form the department of Health which can be found on the COEJ website for others.

Please note that this article is to be used as a guide to discuss the matter with your GP/Diabetic nurse but follow their advice.

Who should not FAST

Type 1
If you had severe Hypo previously
Ketoacidosis previously
Poor Glycaemic control (>10%)
Complications- Kidneys problems
Pregnant
Acute illness

Adjusting Medication

Metformin, Glitazones & Repaglinide ( No change)
Gliclazide – No change to evening dose
Glibenclamide-- Change to Gliclaside
Glimepride -- Take in evening

Testing During Ramadan

Metfromin & Glitazone – No testing
Gliclazide /Glimepride – need meter.
(Test if symptoms of hypo’s.)

When FAST must END

Hypo ( <3.5mmol)
BG <3.9mmols within few hours of fast
BG more than 16mmols.

Please seek assistance of your GP or diabetic nurse if in doubt.

This guidance has been prepared by the volunteers to the Health Improvement Board of the Council of European
Jamaats.

Add this to your website

HIB - Health Advice

Latest Updates

Popular Items

The Council of European Jamaats
22 Estreham Road
London, SW16 5PQ
Telephone: +44 (0)845 330 6012
Fax: +44 (0)845 330 6014
Email: secretariat@coej.org
Registered Charity in UK No: 1096111